Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against SelectQuote, Inc. due to allegations of violations of federal securities laws related to misleading statements and illegal kickbacks [4][6][7] Group 1: Allegations Against SelectQuote - The complaint alleges that SelectQuote directed Medicare beneficiaries to plans that compensated the company best, regardless of quality [6] - SelectQuote is accused of failing to provide unbiased comparisons for Medicare Advantage insurance plans [6] - The company allegedly received illegal kickbacks from health insurers to steer beneficiaries towards certain plans, limiting enrollment in competitors' offerings [6] - SelectQuote's actions reportedly made it vulnerable to regulatory and legal sanctions, including violations of the False Claims Act [6] - The U.S. Department of Justice filed a complaint stating that SelectQuote received "tens of millions of dollars" in illegal kickbacks from 2016 to 2021 [7] Group 2: Impact on Stock and Legal Proceedings - Following the DOJ's allegations, SelectQuote's stock price fell by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, with unusually high trading volume [7] - Investors who suffered losses are encouraged to contact Faruqi & Faruqi to discuss their legal rights and options [4][9] - There is an October 10, 2025 deadline for investors to seek the role of lead plaintiff in the federal securities class action against SelectQuote [4]

Core Viewpoint - The article discusses a class action lawsuit against SelectQuote, Inc. due to allegations of receiving illegal kickbacks from health insurance companies and misleading investors about its business practices [1][2][3]. Group 1: Allegations and Legal Actions - The U.S. Department of Justice filed a False Claims Act complaint against SelectQuote, alleging that from 2016 to at least 2021, the company received "tens of millions of dollars" in illegal kickbacks for steering Medicare beneficiaries to specific insurers [2]. - SelectQuote is accused of making materially false claims regarding its services, claiming to offer unbiased coverage comparisons while directing beneficiaries to plans that paid the most [2][3]. - The class action lawsuit alleges that SelectQuote failed to disclose critical information about its operations, including the receipt of illegal kickbacks and non-compliance with applicable laws [3]. Group 2: Financial Impact - Following the DOJ's announcement, SelectQuote's stock price dropped by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, with unusually high trading volume [2]. Group 3: Class Action Participation - Investors who purchased SelectQuote securities during the specified Class Period (September 9, 2020, to May 1, 2025) have until October 10, 2025, to file a lead plaintiff motion in the class action lawsuit [1][4].